دورية أكاديمية
أعرض في EDS

Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.

التفاصيل البيبلوغرافية
العنوان: Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.
المؤلفون: Tazinkeng NN; Faculty of Health Sciences, University of Buea, Buea, Cameroon.; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; Department of Population Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA., Teuwafeu DG; Faculty of Health Sciences, University of Buea, Buea, Cameroon.; Department of Internal Medicine, Buea Regional Hospital, Buea, Cameroon., Asombang AW; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Agbor VN; Department of Population Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Bloom SM; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Nkhoma AN; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; University Hospital of the North Midlands NHS Trust, Stoke-on-Trent, UK., Mohareb AM; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA., Luma HN; Douala General Hospital, Douala, Cameroon.
المصدر: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Nov; Vol. 42 (11), pp. 2396-2402. Date of Electronic Publication: 2022 Aug 24.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE
أسماء مطبوعة: Publication: Malden, MA : Wiley-Blackwell
Original Publication: Oxford, UK : Blackwell Munksgaard, c2003-
مواضيع طبية MeSH: HIV Infections*/complications , Hepatitis B*/diagnosis , Hepatitis C*/complications , Hepatitis C*/diagnosis , Hepatitis C*/epidemiology, Adolescent ; Adult ; Aged ; Antigens, Surface ; Cameroon/epidemiology ; Cross-Sectional Studies ; Female ; Hepacivirus ; Hepatitis B Surface Antigens ; Hepatitis C Antibodies ; Humans ; Male ; Prevalence ; Risk Factors ; Young Adult
مستخلص: Introduction: Viral hepatitis is a major cause of death in Africa. A paucity of community-based studies on the determinants of viral hepatitis in Africa impedes efforts to appropriately target prevention, screening, and treatment interventions. We assessed factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) in a semi-urban health district in Cameroon.
Methods: We conducted a community-based, cross-sectional study from 28 February to 15 May 2021 in the Buea Health District in Buea, Cameroon. We recruited a sample of consenting individuals aged over 15 years old. Participants were surveyed for factors associated with HBV/HCV and were screened for HBV surface antigen (HBsAg) and HCV antibody using rapid point-of-care tests. We performed univariable and multivariable logistic regression analyses to identify factors associated with HBsAg and HCV seropositivity.
Results: We screened 1144 participants (66% female) with a median age of 30 years (IQR: 23-44). HBsAg prevalence was 5.7% (95%CI: 4.5-7.2%) and HCV seropositivity was 1.9% (95%CI: 1.3-2.9%). Three people (0.3%) were seropositive for both HBsAg and HCV antibody. Male sex (adjusted OR [aOR] = 2.31; 95%CI: 1.28-4.18) and a history of traditional operation or scarification (aOR = 2.87; 95%CI: 1.67-4.92) were associated with HBsAg. None of the assessed factors was significantly associated with HCV antibody.
Conclusion: Men and participants with a history of traditional operation and scarification had higher odds of HBsAg. We did not observe any associations with HCV seropositivity. Prevention and screening efforts among adults in this setting should prioritize men and those with a history of traditional operation and scarification.
(© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
References: World Health Organization. Global hepatitis report 2017. Available from: https://www.who.int/publications-detail-redirect/global-hepatitis-report-2017.
Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2(12):900-909.
Lingani M, Akita T, Ouoba S, et al. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey. BMC Infect Dis. 2020;20(1):46.
Breakwell L, Tevi-Benissan C, Childs L, et al. The status of hepatitis B control in the African region. Pan Afr Med J. 2017;27(Suppl 3):17.
Bartenschlager R, Baumert TF, Bukh J, et al. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. Virus Res. 2018;248:53-62.
World Health Organization. Hepatitis C: fact sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
UNAIDS. Global AIDS Update 2016. Available from: https://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016.
World Health Organization | Global health sector strategy on viral hepatitis 2016-2021 WHO. Available from: http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
Frambo AAB, Atashili J, Fon PN, Ndumbe PM. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study. BMC Res Notes. 2014;7(1):394.
Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes. 2014;24(7):833.
Ziraba AK, Bwogi J, Namale A, Wainaina CW, Mayanja-Kizza H. Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis. 2010;29(10):191.
Rahamane Njigou A, Tochie JN, Danwang C, et al. Seroprevalence of hepatitis B and C infections in Mokolo District Hospital, Northern Cameroon: the value of a screening campaign. Hosp Pract Res. 2018;3(3):79-84.
McNaughton AL, Lourenço J, Bester PA, et al. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med. 2020;17(4):e1003068.
Bigna JJ, Amougou MA, Asangbeh SL, et al. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open. 2017;7(6):e015298.
Riou J, Aït Ahmed M, Blake A, et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. J Viral Hepat. 2016;23(4):244-255.
Eyong EM, Yankam BM, Seraphine E, et al. The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka health districts of the South West region of Cameroon: a three-year retrospective study. Pan Afr Med J. 2019;32:122.
Fouelifack FY, Fouedjio JH, Fouogue JT, Fouelifa LD. Seroprevalences and correlates of hepatitis B and C among cameroonian pregnant women. Clin Med Insights Reprod Health. 2018;12:117955811877067.
Fouelifack Ymele F, Keugoung B, Fouedjio JH, Kouam N, Mendibi S, Dongtsa Mabou J High rates of hepatitis B and C and HIV infections among blood donors in Cameroon: a proposed blood screening algorithm for blood donors in resource-limited settings. J Blood Transfus 2012; 2012:e458372, 2012, 1, 7.
Cameroon: displacement estimates in South-West region (as of 16 August 2018) - Cameroon. ReliefWeb. Available from: https://reliefweb.int/report/cameroon/cameroon-displacement-estimates-south-west-region-16-august-2018.
Stata: Software for Statistics and Data Science. Available from: https://www.stata.com/.
Makuza JD, Rwema JOT, Ntihabose CK, et al. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infect Dis. 2019;19(1):381.
Noubiap JJN, Joko WYA, Nansseu JRN, Tene UG, Siaka C Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon Int J Infect Dis 2013; 17(10):e832-e837.
Papageorgiou G, Grant SW, Takkenberg JJM, Mokhles MM. Statistical primer: how to deal with missing data in scientific research? Interact Cardiovasc Thoracic Surg. 2018;27(2):153-158.
Njai HF, Shimakawa Y, Sanneh B, et al. Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in The Gambia, Western Africa. J Clin Microbiol. 2015;53(4):1156-1163.
Lemoine M, Shimakawa Y, Njie R, et al. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. Lancet Glob Health. 2016;4(8):e559- e567.
Ankouane F, Tagni-Sartre M, Noah Noah D, et al. Prevalence of the hepatitis B surface antigen in a population of workers in Cameroon. Open J Gastroenterol. 2013;3:323-327.
Noubiap JJN, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN. Hepatitis B and C co-infections in some HIV-positive populations in Cameroon, West Central Africa: analysis of samples collected over more than a decade. PloS One. 2015;10(9):e0137375.
Iradukunda PG, Habyarimana T, Niyonzima FN, et al. Risk factors associated with hepatitis B and C in rural population of Burera district, Rwanda. Pan Afr Med J. 2020;35(43):43.
Tadongfack TD, Keubo FRN, Bianke P. Hepatitis B infection in the rural area of Dschang, Cameroon: seroprevalence and associated factors. Pan Afr Med J. 2020;36:362.
Agbor AM, Naidoo S, Mbia AM. The role of traditional healers in tooth extractions in Lekie Division, Cameroon. J Ethnobiol Ethnomedicine. 2011;7(1):15.
Miles SH, Ololo H. Traditional surgeons in sub-Saharan Africa: images from South Sudan. Int J STD AIDS. 2003;14(8):505-508.
Agbor AM, Naidoo S. Knowledge and practice of traditional healers in oral health in the Bui Division, Cameroon. J Ethnobiol Ethnomedicine. 2011;7(1):6.
Tsiba JB, Mabiala-Babela JR, Lenga LI, et al. Scarification in children hospitalized in Congo. Med Trop Rev Corps Sante Colon. 2011;71(5):509-510.
Babatunde O, Oyeronke A. Scarification practice and scar complications among the Nigerian Yorubas. Indian J Dermatol Venereol Leprol. 2010;76(5):571-572.
Ibadin OM, Ofili AN, Airauhi LU, Ozolua EI, Umoru AB. Splenic enlargement and abdominal scarifications in childhood malaria: beliefs, practices and their possible roles in management as seen in Benin City, Nigeria. Niger Postgrad Med J. 2008;15(2):70-75.
Garve R, Garve M, Türp JC, Fobil JN, Meyer CG. Scarification in sub-Saharan Africa: social skin, remedy and medical import. Trop Med Int Health. 2017;22(6):708-715.
فهرسة مساهمة: Keywords: Africa; Cameroon; hepatitis B; hepatitis C; risk factors
المشرفين على المادة: 0 (Antigens, Surface)
0 (Hepatitis B Surface Antigens)
0 (Hepatitis C Antibodies)
تواريخ الأحداث: Date Created: 20220810 Date Completed: 20220928 Latest Revision: 20221122
رمز التحديث: 20240628
DOI: 10.1111/liv.15390
PMID: 35946051
قاعدة البيانات: MEDLINE
الوصف
تدمد:1478-3231
DOI:10.1111/liv.15390